Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 81 publications
Longitudinal Assessment of Biomarkers in ALS: Discriminative Biomarkers for Disease Progression and Survival.
Journal: Annals of clinical and translational neurology
Published: February 12, 2026
Integrated single-cell and spatial transcriptomic profiling in ALS uncovers peripheral-to-central immune infiltration and reprogramming.
Journal: Nature neuroscience
Published: October 07, 2025
Peripheral immune profiling in frontotemporal dementia.
Journal: Brain communications
Published: September 23, 2025
CNM-Au8 in Amyotrophic Lateral Sclerosis: The HEALEY ALS Platform Trial.
Journal: JAMA
Published: March 11, 2025
Pridopidine in Amyotrophic Lateral Sclerosis: The HEALEY ALS Platform Trial.
Journal: JAMA
Published: March 11, 2025
Low-dose interleukin-2 in patients with mild to moderate Alzheimer's disease: a randomized clinical trial.
Journal: Alzheimer's research & therapy
Published: March 10, 2025
Efficacy and Safety of Zilucoplan in Amyotrophic Lateral Sclerosis: A Randomized Clinical Trial.
Journal: JAMA network open
Published: February 17, 2025
Peripheral monocyte transcriptional signatures of inflammation and oxidative stress in Parkinson's disease.
Journal: Frontiers in immunology
Published: February 04, 2025
Barriers to Tofersen Therapy for Variant SOD1-Mediated ALS.
Journal: JAMA neurology
Published: October 07, 2024
A phase 1 proof-of-concept study evaluating safety, tolerability, and biological marker responses with combination therapy of CTLA4-Ig and interleukin-2 in amyotrophic lateral sclerosis.
Journal: Frontiers in neurology
Published: April 09, 2024
Last Updated: 09/26/2026